Share story
Products

Apple adds M6 chips to iMac and entry-level MacBook Pro

An array of iMacs in different colors Image: Primary
Apple announced M6 versions of the iMac and entry-level 14-inch MacBook Pro, extending the chip beyond the Mac mini. The iMac moves directly from M4 to M6, skipping M5. The two-port iMac has a 10-core CPU and 10-core GPU, with configurations capped at 24 GB of RAM and 1TB of storage. The four-port version has 12 CPU and GPU cores and supports up to 32GB of RAM and 2TB of storage. The MacBook Pro uses the 12-core CPU and GPU configuration, supporting up to 32GB of RAM and 4TB of storage. Apple's M6 performance comparisons are against M4; Ars Technica said its earlier Mac mini testing largely matched those claims.
Sources
Ars Technica
In this story
Apple
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Ars Technica and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Former Benchmark investors raise $1.252 billion for Diffusion ONE

Former Benchmark investors Victor Lazarte and Kris Fredrickson have raised $1.252 billion for their debut AI fund, Diffusion ONE, TechCrunch reported from SEC filings. The total exceeds the $800 million target Forbes reported in M...

Venture Capital News | TechCrunch
Products Capital
Products Capital

Hex announces $100 million financing and rebuilt analytics platform

Hex says it closed a $100 million financing round at a $1.2B valuation and introduced Hex 4.0, a rewrite of its analytics platform. PeakXV and 137 Ventures led the round, with participation from Amplify, Avra, a16z, Redpoint, Sequ...

hex.tech
Infrastructure Products
Infrastructure Products

ASM raises 2027 revenue forecast to more than €5.7B

ASM International raised its 2027 revenue forecast to more than €5.7B from above €4.6B forecast in July, as memory and advanced AI chipmakers expand production. The chip-equipment maker said the revised outlook would reach its 203...

The Next Web
Capital AI
Capital AI

Anthropic acquires Mithril Medicine and starts its own drug research

Anthropic says it has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, and begun running drug discovery programs itself. Founder Cody Tranbarger is continuing the rese...

anthropic.com